Ribosomal protein S27 pseudogene 5 (RPS27P5)

**Ribosomal protein S27 pseudogene 5 (RPS27P5)** is annotated as a processed pseudogene derived from the ribosomal protein S27 (RPS27) gene[5][6]. Pseudogenes are gene sequences that resemble known genes but are generally considered non-functional due to mutations such as premature stop codons or frameshifts, and RPS27P5 fits this definition by sequence analysis[6]. However, emerging research indicates that some ribosomal protein pseudogenes, including the closely related RPS27AP5, can be transcribed and translated to yield variant proteins that may integrate into ribosomes and contribute to ribosomal diversity, specifically under distinct cellular contexts[2][4]. Even so, these findings are preliminary, and RPS27P5 itself has not been validated as a functional gene, therapeutic target, biomarker, or disease driver. It is included in the genome as a pseudogene with no established role in pharmacology or disease, and current evidence does not support its classification as a conventional molecular target for therapy[6][2]. **Additional context:** - The existence of several ribosomal protein pseudogenes in the human genome highlights genomic drift and evolutionary history, not functional necessity[6]. - The main canonical ribosomal protein S27 (RPS27) and its paralog RPS27L have distinct cellular roles, but pseudogenes like RPS27P5 are not functionally characterized as targets or disease-associated genes[3]. - Recent studies on ribosomal protein pseudogenes have observed rare translation and integration into ribosomal subunits (notably for RPS27AP5), but such activities remain under investigation and do not constitute established biological or therapeutic relevance for RPS27P5 itself[2][4].

Other names

RPS27_4_170Ribosomal protein S27-like pseudogeneRPS27P5